Loading...
StocksRunner logo
 
 
Arch Capital Group
71.38
+0.55%
 
ACGL Arch Capital Group
Last Price
Change
71.38
 
+0.55%
 
 
 

 
Sentiment
 
 

76

63.15

61.35

44.73

 
 
1m
3m
6m
1y
 

Summary

  Login to display Arch Capital Group (ACGL) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Upgraded on attractively valued

Rewards

 Outperform the market

 

Risk Analysis

Risk Analysis

 Insider selling during the past 3 months

 

Technical Indicators

Technical Indicators

 MACD crosses above signal line

 
 

Risk Level

 
StocksRunner
 

Arch Capital Group (ACGL) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Earnings increase YoY

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

2.00
 
 

Activity

×
 

Activity

2.67
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

4.71
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is positive and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
82%
100%
0%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
82%
18%
Positive
Negative
14 out of 17
events present
3 out of 17
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Buy Rating
1 Day Ago
71.38
+0.55%
 
Insider Selling
2 Weeks Ago
71.75
-1.95%
 
Options Activity
2 Month Ago
75.90
0.00%
 
Strong Earnings
2 Month Ago
73.88
+2.20%
 
Buy Rating
2 Month Ago
71.68
-0.71%
 
Top Headlines

research capital corporation maintains theratechnologies (tsx:th) buy recommendation. fintel reports that on june 4 2023 research capital corporation maintained coverage of theratechnologies (tsx:th) with a buy recommendation.

Fri Jun 9, 2023

Rating

$100 invested in this stock 15 years ago would be worth $900 today. arch capital group (nasdaq:) has outperformed the market over the past 15 years by 7.83% on an annualized basis producing an average annual return of 15.77%. currently arch capital group

Mon Jun 5, 2023

Activity

heres why arch capital group (acgl) is a strong value stock. taking full advantage of the stock market and investing with confidence are common goals for new and old investors and zacks premium

Tue May 30, 2023

Potential

arch capital group ceo sold $15.22m in company stock. ) reported a large insider sell on may 23 according to a new sec filing. United States securities and exchange commissi

Wed May 24, 2023

Activity

heres why hold strategy is apt for arch capital (acgl). arch capital group ltd. acgl is well-poised for growth driven by new business opportunities rate increases solid growth within professional liability and travel business units and

Wed May 10, 2023

Potential

peering into arch capital groups recent short interest. ) short percent of float has risen 21.15% since its last report. the company recently reported that it has

Wed May 10, 2023

Activity

unusual put option trade in arch capital group (acgl) worth $172.82k. on may 1 2023 at 14:35:37 et an unusually large $172.82k block of put contracts in arch capital group (acgl) was sold with a strike price of $70.00 / shar

Tue May 2, 2023

Momentum

keefe bruyette & woods maintains arch capital group (acgl) outperform recommendation. fintel reports that on may 1 2023 keefe bruyette &. woods maintained coverage of arch capital group (nasdaq:acgl) with a outperform recom

Mon May 1, 2023

Potential

wells fargo maintains arch capital group (acgl) overweight recommendation. fintel reports that on april 28 2023 wells fargo maintained coverage of arch capital group (nasdaq:acgl) with a overweight recommendation.

Fri Apr 28, 2023

Rating

barclays maintains arch capital group (acgl) overweight recommendation. fintel reports that on april 28 2023 barclays maintained coverage of arch capital group (nasdaq:acgl) with a overweight recommendation.

Fri Apr 28, 2023

Rating

arch capital (acgl) q1 earnings and revenues top rise y/y. arch capital group ltd. acgl reported first-quarter 2023 operating income of $1.73 per share beating the zacks consensus estimate by 14.6%. earnings also came ahead of our esti

Thu Apr 27, 2023

Earnings

jmp securities maintains arch capital group (acgl) outperform recommendation. fintel reports that on april 27 2023 jmp securities maintained coverage of arch capital group (nasdaq:acgl) with a outperform recommendation.

Thu Apr 27, 2023

Potential

research capital corporation maintains canyon copper (tsxv:cnc) buy recommendation. fintel reports that on april 13 2023 research capital corporation maintained coverage of canyon copper (tsxv:cnc) with a buy recommendation.

Fri Apr 21, 2023

Rating

research capital corporation maintains theratechnologies (tsx:th) buy recommendation. fintel reports that on april 13 2023 research capital corporation maintained coverage of theratechnologies (tsx:th) with a buy recommendatio

Fri Apr 21, 2023

Rating

arch capital group (acgl) reports next week: wall street expects earnings growth. the market expects arch capital group (acgl) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter

Wed Apr 19, 2023

Potential

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily ACGL alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

ACGL Arch Capital Group

Last Price
71.38
Change
+0.55%
 

Summary

  Login to display Arch Capital Group (ACGL) recommendation from the last 90 days from financial news and social media.

 
 
76
63.15
61.35
44.73
 
 
1m
3m
6m
1y
 
Sentiment

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Upgraded on attractively valued

Rewards

 Outperform the market

Risk Analysis

Risk Analysis

 Insider selling during the past 3 months

Technical Indicators

Technical Indicators

 MACD crosses above signal line

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
100%
0%
100%
On Track
On Track
On Track
 
82%
18%
Positive
Negative
14 out of 17
events present
3 out of 17
events present
 

Street Opinion

Street view is extremely ish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Earnings increase YoY

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

2.00
 
 

Activity

×
 

Activity

2.67
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

4.71
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is positive and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Arch Capital Group (ACGL) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Buy Rating
1 Day Ago
71.38
+0.55%
 
Insider Selling
2 Weeks Ago
71.75
-1.95%
 
Options Activity
2 Month Ago
75.90
0.00%
 
Strong Earnings
2 Month Ago
73.88
+2.20%
 
Buy Rating
2 Month Ago
71.68
-0.71%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily ACGL Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines